JNJ

227.46

+0.25%↑

ISRG

503.04

-3.51%↓

ABT

105.97

-0.11%↓

MDT

100.49

-0.34%↓

132.5

-1.62%↓

JNJ

227.46

+0.25%↑

ISRG

503.04

-3.51%↓

ABT

105.97

-0.11%↓

MDT

100.49

-0.34%↓

132.5

-1.62%↓

JNJ

227.46

+0.25%↑

ISRG

503.04

-3.51%↓

ABT

105.97

-0.11%↓

MDT

100.49

-0.34%↓

132.5

-1.62%↓

JNJ

227.46

+0.25%↑

ISRG

503.04

-3.51%↓

ABT

105.97

-0.11%↓

MDT

100.49

-0.34%↓

132.5

-1.62%↓

JNJ

227.46

+0.25%↑

ISRG

503.04

-3.51%↓

ABT

105.97

-0.11%↓

MDT

100.49

-0.34%↓

132.5

-1.62%↓

Home・Akcijų sąrašas・VolitionRX Ltd

VolitionRX Ltd

Atidarymo kaina

0.25

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.24

Max

0.26

Pagrindiniai rodikliai
By Trading Economics
Pajamos	936K -5.4M
Pardavimai	221K 627K
Pelno marža	-857.414
Darbuotojai	75
EBITDA	1.3M -4.2M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+733.33% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-30

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-14M 33M
Ankstesnė atidarymo kaina	0.25
Ankstesnė uždarymo kaina	0.25

VolitionRX Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-28 23:51; UTC

Uždarbis

Correction to Samsung Fourth-Quarter Net Profit Article

2026-01-28 23:49; UTC

Karštos akcijos

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

2026-01-28 23:19; UTC

Uždarbis

Samsung's Fourth-Quarter Net Profit Beats Consensus

2026-01-28 22:43; UTC

Uždarbis

Waste Management Logs Higher 4Q Profit as Revenue Rises

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

2026-01-29 00:00; UTC

Įsigijimai, susijungimai, perėmimai

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

2026-01-28 23:49; UTC

Rinkos pokalbiai

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026-01-28 23:30; UTC

Rinkos pokalbiai

Tesla to Use Car Factory for Robot Aims -- Market Talk

2026-01-28 23:28; UTC

Uždarbis

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

2026-01-28 23:26; UTC

Uždarbis

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

2026-01-28 23:21; UTC

Uždarbis

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

2026-01-28 23:18; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

2026-01-28 22:58; UTC

Uždarbis

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

2026-01-28 22:48; UTC

Rinkos pokalbiai

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

2026-01-28 22:45; UTC

Uždarbis

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

2026-01-28 22:44; UTC

Uždarbis

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

2026-01-28 22:43; UTC

Uždarbis

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

2026-01-28 22:41; UTC

Uždarbis

Karštos akcijos

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

2026-01-28 22:41; UTC

Rinkos pokalbiai

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

2026-01-28 22:41; UTC

Uždarbis

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

2026-01-28 22:40; UTC

Uždarbis

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

2026-01-28 22:39; UTC

Uždarbis

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

2026-01-28 22:38; UTC

Uždarbis

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

2026-01-28 22:37; UTC

Uždarbis

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

2026-01-28 22:35; UTC

Uždarbis

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

2026-01-28 22:26; UTC

Rinkos pokalbiai

Uždarbis

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

2026-01-28 22:20; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-28 22:20; UTC

Rinkos pokalbiai

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Akcijų palyginimas

Kainos pokytis

VolitionRX Ltd Prognozė

Kainos tikslas

By TipRanks

733.33% į viršų

12 mėnesių prognozė

Vidutinis 2.25 USD 733.33%

Aukščiausias 3 USD

Žemiausias 1.5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines VolitionRX Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių VolitionRX Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.